Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402 Download the PDF here. This post appeared first on investingnews.com 0 FacebookTwitterPinterestEmail previous post Significant Milestone Achieved in Development Journey with The Completion of The “first phase” of the Environmental Impact Assessment Procedure for Rajapalot Gold-Cobalt Project next post Capital Raising and QSM Completion Update Related Posts Missouri Set to Recognize Gold and Silver as Legal Tender,... May 13, 2025 Heaven’s Earthly Treasures: Behind the Metallurgy of the Papal Symbols May 13, 2025 Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based... May 13, 2025 John Feneck: Key Gold, Silver Price Levels, 10+ Mining Stocks... May 13, 2025 Web3 Leaders Gather in Toronto for Canada Crypto Week May 13, 2025 Pan American to Buy MAG Silver in US$2.1 Billion Deal,... May 13, 2025
